Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Below 50 Day Moving Average – Here’s Why

Shares of Faron Pharmaceuticals Oy (LON:FARN) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 39.74 and traded as low as GBX 34.04. Faron Pharmaceuticals Oy shares last traded at GBX 34.04, with a volume of 13,565 shares.

Faron Pharmaceuticals Oy Trading Up 2.9%

The stock has a fifty day simple moving average of GBX 39.60 and a 200 day simple moving average of GBX 42.81. The firm has a market capitalization of £73.04 million, a P/E ratio of -3.13 and a beta of 1.12. The company has a quick ratio of 1.09, a current ratio of 2.40 and a debt-to-equity ratio of 154.15.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.